28964 Federal Register / Vol. 70, No.
96 / Thursday, May 19, 2005 / Notices
NUCLEAR REGULATORY
COMMISSION
[Docket No. 030–02489]
Notice of Availability of Environmental
Assessment and Finding of No
Significant Impact for License
Amendment for Princeton Healthcare
System’s Facility in Princeton, NJ
AGENCY: Nuclear Regulatory
Commission.
ACTION: Notice of availability.
FOR FURTHER INFORMATION CONTACT:
Sandra Gabriel, Medical Branch,
Division of Nuclear Materials Safety,
Region I, 475 Allendale Road, King of
Prussia, Pennsylvania 19406, telephone
(610) 337–5182, fax (610) 337–5269; or
by e-mail: slg2@nrc.gov.
SUPPLEMENTARY INFORMATION:
I. Introduction
The Nuclear Regulatory Commission
(NRC) is issuing a license amendment to
Princeton HealthCare System for
Materials License No. 29–06750–01, to
authorize release of its facility at
Princeton House Behavioral Health, 905
Herrontown Road in Princeton, New
Jersey for unrestricted use. NRC has
prepared an Environmental Assessment
(EA) in support of this action in
accordance with the requirements of 10
CFR Part 51. Based on the EA, the NRC
has concluded that a Finding of No
Significant Impact (FONSI) is
appropriate. The amendment will be
issued following the publication of this
Notice.
II. EA Summary
The purpose of the action is to
authorize the release of the licensee’s
facility at Princeton House Behavioral
Health, 905 Herrontown Road in
Princeton, New Jersey, for unrestricted
use. Princeton HealthCare System was
authorized by NRC from July 21, 1993,
to use radioactive materials at this site
for research and development involving
absorption, dilution, metabolism, and
excretion studies in humans, in
association with Bristol Myers Squibb.
In 1998, Princeton HealthCare System
ceased operations with licensed
materials at the Princeton House
Behavioral Health site, and in 2004
requested that NRC release the facility
for unrestricted use. Princeton
HealthCare System has conducted
surveys of the facility and determined
that the facility meets the license
termination criteria in Subpart E of 10
CFR Part 20.
The NRC staff has prepared an EA in
support of the license amendment. The
VerDate jul<14>2003 22:14 May 18, 2005 Jkt 205001
facility was remediated and surveyed
prior to the licensee requesting the
license amendment. The NRC staff has
reviewed the information and final
status survey submitted by Princeton
HealthCare System. Based on its review,
the staff has determined that there are
no additional remediation activities
necessary to complete the proposed
action. Therefore, the staff considered
the impact of the residual radioactivity
at the facility and concluded that since
the residual radioactivity meets the
requirements in Subpart E of 10 CFR
Part 20, a Finding of No Significant
Impact is appropriate.
III. Finding of No Significant Impact
The staff has prepared the EA
(summarized above) in support of the
license amendment to release the
facility at Princeton House Behavioral
Health, 905 Herrontown Road Way in
Princeton, New Jersey, for unrestricted
use. The NRC staff has evaluated
Princeton HealthCare System’s request
and the results of the surveys and has
concluded that the completed action
complies with the criteria in Subpart E
of 10 CFR Part 20. On the basis of the
EA, the NRC has concluded that the
environmental impacts from the action
are expected to be insignificant and has
determined not to prepare an
environmental impact statement for the
action.
IV. Further Information
Documents related to this action,
including the application for the license
amendment and supporting
documentation, are available
electronically at the NRC’s Electronic
Reading Room at http://www.nrc.gov/
reading-rm/adams.html. From this site,
you can access the NRC’s Agencywide
Document Access and Management
System (ADAMS), which provides text
and image files of NRC’s public
documents. The ADAMS accession
numbers for the documents related to
this Notice are: Environmental
Assessment (ML050900333), letter dated
November 24, 2004 with attached
closeout survey results (ML043410218),
and letter dated March 14, 2005
(ML050830030). Persons who do not
have access to ADAMS or who
encounter problems in accessing the
documents located in ADAMS, should
contact the NRC PDR Reference staff by
telephone at (800) 397–4209 or (301)
415–4737, or by email to pdr@nrc.gov.
These documents may also be
examined, and/or copied for a fee, at the
NRC PDR, located at One White Flint
North, 11555 Rockville Pike (First
Floor), Rockville, MD 20852. The PDR is
open from 7:45 a.m. to 4:15 p.m.,
PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 E:\FR\FM\19MYN1.SGM
Monday through Friday, except on
Federal Holidays; and at the Region I
Office, 475 Allendale Road, King of
Prussia, Pennsylvania 19406.
Dated at King of Prussia, Pennsylvania this
10th day of May, 2005.
For the Nuclear Regulatory Commission.
Pamela J. Henderson,
Chief, Medical Branch, Division of Nuclear
Materials Safety, Region I.
[FR Doc. E5–2509 Filed 5–18–05; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
Advisory Committee on Reactor
Safeguards; Subcommittee Meeting on
Planning and Procedures; Notice of
Meeting
The ACRS Subcommittee on Planning
and Procedures will hold a meeting on
May 31, 2005, Room T–2B1, 11545
Rockville Pike, Rockville, Maryland.
The entire meeting will be open to
public attendance, with the exception of
a portion that may be closed pursuant
to 5 U.S.C. 552b(c)(2) and (6) to discuss
organizational and personnel matters
that relate solely to the internal
personnel rules and practices of the
ACRS, and information the release of
which would constitute a clearly
unwarranted invasion of personal
privacy.
The agenda for the subject meeting
shall be as follows:
Tuesday, May 31, 2005—10 a.m.–11:30
a.m.
The Subcommittee will discuss
proposed ACRS activities and related
matters. The Subcommittee will gather
information, analyze relevant issues and
facts, and formulate proposed positions
and actions, as appropriate, for
deliberation by the full Committee.
Members of the public desiring to
provide oral statements and/or written
comments should notify the Designated
Federal Official, Mr. Sam Duraiswamy
(telephone: 301–415–7364) between
7:30 a.m. and 4:15 p.m. (ET) five days
prior to the meeting, if possible, so that
appropriate arrangements can be made.
Electronic recordings will be permitted
only during those portions of the
meeting that are open to the public.
Further information regarding this
meeting can be obtained by contacting
the Designated Federal Official between
7:30 a.m. and 4:15 p.m. (ET). Persons
planning to attend this meeting are
urged to contact the above named
individual at least two working days
prior to the meeting to be advised of any
potential changes in the agenda.
19MYN1
 Federal Register / Vol. 70, No. 96 / Thursday, May 19, 2005 / Notices
Dated: May 11, 2005.
Michael R. Snodderly,
Acting Branch Chief, ACRS/ACNW.
[FR Doc. E5–2510 Filed 5–18–05; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
Advisory Committee on Reactor
Safeguards Meeting of the
Subcommittee on Plant License
Renewal; Notice of Meeting
The ACRS Subcommittee on Plant
License Renewal will hold a meeting on
May 31, 2005, Room T–2B3, 11545
Rockville Pike, Rockville, Maryland.
The entire meeting will be open to
public attendance.
The agenda for the subject meeting
shall be as follows:
Tuesday, May 31, 2005—12:30 p.m.
until 5 p.m.
The purpose of this meeting is to
discuss the License Renewal
Application and associated Safety
Evaluation Report (SER) with Open
Items related to the License Renewal of
the Point Beach Nuclear Plant, Units 1
and 2. The Subcommittee will hear
presentations by and hold discussions
with representatives of the NRC staff,
the Nuclear Management Company,
LLC, and other interested persons
regarding this matter. The
Subcommittee will gather information,
analyze relevant issues and facts, and
formulate proposed positions and
actions, as appropriate, for deliberation
by the full Committee.
Members of the public desiring to
provide oral statements and/or written
comments should notify the Designated
Federal Official, Mr. Cayetano Santos
(telephone 301–415–7270) five days
prior to the meeting, if possible, so that
appropriate arrangements can be made.
Electronic recordings will be permitted.
Further information regarding this
meeting can be obtained by contacting
the Designated Federal Official between
7:30 a.m. and 4:15 p.m. (ET). Persons
planning to attend this meeting are
urged to contact the above named
individual at least two working days
prior to the meeting to be advised of any
potential changes to the agenda.
Dated: May 11, 2005.
Michael R. Snodderly,
Acting Branch Chief, ACRS/ACNW.
[FR Doc. E5–2511 Filed 5–18–05; 8:45 am]
BILLING CODE 7590–01–P
VerDate jul<14>2003 22:14 May 18, 2005 Jkt 205001
SECURITIES AND EXCHANGE
COMMISSION
[Release Nos. IC–26867; File No. S7–11–
04]
RIN 3235–AJ17
Mutual Fund Redemption Fees
AGENCY: Securities and Exchange
Commission.
ACTION: Notice of OMB Approval of
Collections of Information.
FOR FURTHER INFORMATION CONTACT:
William C. Middlebrooks, Jr., Senior
Counsel, Office of Regulatory Policy,
Division of Investment Management,
(202) 551–6792, at the Securities and
Exchange Commission, 450 Fifth Street,
NW., Washington, DC 20549–0506.
SUPPLEMENTARY INFORMATION: The Office
of Management and Budget has
approved the collection of information
requirements described in the release
entitled ‘‘Mutual Fund Redemption
Fees.’’ 1 This collection is titled ‘‘Rule
22c–2’’ (OMB Control No. 3235–0620).
Dated: May 13, 2005.
J. Lynn Taylor,
Assistant Secretary.
[FR Doc. 05–9970 Filed 5–18–05; 8:45 am]
BILLING CODE 8010–01–P
SECURITIES AND EXCHANGE
COMMISSION
[File No. 500–1]
In Sino Silver Corp.; Order of
Suspension of Trading
May 17, 2005.
It appears to the Securities and
Exchange Commission that the public
interest and the protection of investors
require a suspension of trading in the
securities of Sino Silver Corp. (‘‘Sino’’),
trading under the stock symbol SSLV on
the Over-the-Counter Bulletin Board
(‘‘OTCBB’’). The Commission has
concerns about the accuracy and
completeness of information about Sino
contained in press releases and public
filings with the Commission relating to
a change in control over Sino. In
addition, the Commission is concerned
that Sino, its affiliates, and others may
be engaged in the unlawful distribution
of restricted Sino securities through the
OTCBB.
The Commission is of the opinion that
the public interest and the protection of
investors require a suspension of trading
in the securities of the above listed
company.
1 Investment Company Act Rel. No. 26782 (Mar.
11, 2005) [70 FR 13328 (Mar. 18, 2005)].
PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 E:\FR\FM\19MYN1.SGM
28965
Therefore, it is ordered, pursuant to
Section 12(k) of the Securities Exchange
Act of 1934, that trading in the above
listed company is suspended for the
period from 9:30 a.m. EST, May 17,
2005 through 11:59 p.m. EST, on May
31, 2005.
By the Commission.
Jonathan G. Katz,
Secretary.
[FR Doc. 05–10091 Filed 5–17–05; 11:39 am]
BILLING CODE 8010–01–P
SECURITIES AND EXCHANGE
COMMISSION
[Release No. 34–51689; File No. SR–Amex–
2005–039]
Self-Regulatory Organizations;
American Stock Exchange LLC; Notice
of Filing and Immediate Effectiveness
of Proposed Rule Change Relating to
Revisions to the Series 4 Examination
Program
May 12, 2005.
Pursuant to Section 19(b)(1) of the
Securities Exchange Act of 1934
(‘‘Act’’) 1 and Rule 19b–4 thereunder,2
notice is hereby given that on April 8,
2005, the American Stock Exchange LLC
(‘‘Amex’’ or ‘‘Exchange’’) filed with the
Securities and Exchange Commission
(‘‘Commission’’) the proposed rule
change as described in Items I, II, and
III below, which Items have been
prepared by Amex. Amex has
designated the proposed rule change as
one constituting a stated policy,
practice, or interpretation with respect
to the meaning, administration, or
enforcement of an existing rule of Amex
pursuant to Section 19(b)(3)(A)(i) of the
Act 3 and Rule 19b–4(f)(1) thereunder,4
which renders the proposal effective
upon filing with the Commission. The
Commission is publishing this notice to
solicit comments on the proposed rule
change from interested persons.
I. Self-Regulatory Organization’s
Statement of the Terms of Substance of
the Proposed Rule Change
Amex is filing revisions to the study
outline and selection specifications for
the Limited Principal—Registered
Options (Series 4) examination (‘‘Series
4 Examination’’). The proposed
revisions update the material to reflect
changes to the laws, rules, and
regulations covered by the Series 4
Examination.
1 15 U.S.C. 78s(b)(1).
2 17 CFR 240.19b–4.
3 15 U.S.C. 78s(b)(3)(A)(i).
4 17 CFR 240.19b–4(f)(1).
19MYN1